BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6194344)

  • 1. [Cytoplasmic androgen receptors in biopsy specimens of prostatic tumors].
    Kushlinskiĭ NE; Degtiar' VG; Bassalyk LS
    Lab Delo; 1983; (7):18-20. PubMed ID: 6194344
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
    Walsh PC; Greco JM; Tananis CE; Hicks LL; McLoughlin MG; Menon M
    Trans Am Assoc Genitourin Surg; 1977; 69():78-80. PubMed ID: 84428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of androgen receptor in cytosol of human prostatic tissues with a sepharose-linked antibody system.
    Kliman B; MacLaughlin RA; Prout GR
    Prog Clin Biol Res; 1979; 33():85-96. PubMed ID: 93753
    [No Abstract]   [Full Text] [Related]  

  • 7. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor assay in small biopsies of human prostate. Preservation of nuclear receptor from rat ventral prostate by lyophilization.
    de Larminat MA; Scorticati C; Rennie PS; Bruchovsky N
    Prog Clin Biol Res; 1984; 142():247-59. PubMed ID: 6200889
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
    Mobbs BG; Johnson IE; Connolly JG; Clark AF
    J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

  • 11. [Androgen receptors in cytosol in benign prostatic hyperplasia].
    Corrales Hernandez JJ; Miralles Garcia JM; Montero Gomez J; Martin T; Martin Rodriguez M; Gonzalez Buitrago JM
    Rev Clin Esp; 1983 Feb; 168(4):233-7. PubMed ID: 6190202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

  • 13. Steroid hormone receptors in prostatic hyperplasia and prostatic carcinoma.
    Khalid BA; Nurshireen A; Rashidah M; Zainal BY; Roslan BA; Mahamooth Z
    Med J Malaysia; 1990 Jun; 45(2):148-53. PubMed ID: 1725553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of correlations between therapeutic efficacy of anti-androgen therapy in prostatic cancer and androgen receptor content of prostatic cancer tissue].
    Ohno K; Umehara T; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Aug; 75(8):1212-24. PubMed ID: 6513222
    [No Abstract]   [Full Text] [Related]  

  • 15. Some current problems relating to androgen receptor methodology.
    Geller J; Albert J
    Prog Clin Biol Res; 1979; 33():97-102. PubMed ID: 93754
    [No Abstract]   [Full Text] [Related]  

  • 16. Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.
    Shain SA; Boesel RW
    Invest Urol; 1978 Nov; 16(3):169-74. PubMed ID: 361632
    [No Abstract]   [Full Text] [Related]  

  • 17. [Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
    Gerasimova TsI; Smirnov AN; Rozen VB; Buniatian AF; Bol'shakova TD
    Sov Med; 1984; (6):32-6. PubMed ID: 6205454
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostatic cytoplasmic androgen receptor in prostatic disease. II. Correlation between clinical response to hormonal therapy and change of R1881 receptor content in prostatic cancer during antiandrogenic therapy].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1098-108. PubMed ID: 6334193
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormone-dependency of the human prostate].
    Robel P
    Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of androgen receptors in human prostatic tissue: methodological considerations.
    Walsh PC; McLoughlin MG; Menon M; Tananis C
    Prog Clin Biol Res; 1976; 6():159-68. PubMed ID: 1023206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.